LOADING
Comparing Apple Inc (AAPL) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AAPL | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.56T | $537.4B |
| P/E Ratio | 37.6 | 25.8 |
| Forward P/E | 32.9 | 19.3 |
| PEG Ratio | 2.53 | 2.90 |
| EPS | $8.25 | $8.64 |
| Revenue Growth (YoY) | 16.6% | 9.9% |
| Profit Margin | 27.2% | 21.8% |
| Return on Equity | 141.5% | 26.4% |
| Dividend Yield | 0.33% | 2.33% |
| Beta | 1.06 | 0.26 |
| 52-Week High | $316.94 | $250.24 |
| 52-Week Low | $194.30 | $145.39 |
| Volume | -- | -- |
Apple Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Apple Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.